Literature DB >> 12396938

[The substitution of generic for brand medicines in family medical clinics].

S Casado Buendía1, J K Sagardui Villamor, M Lacalle Rodríguez-Labajo.   

Abstract

OBJECTIVE: To estimate the percentage of patients who change from current medication to generic medicine once properly informed.
DESIGN: Observational, cross-sectional.Setting. Two primary care clinics in Madrid, one rural and the other urban.Participants. Patients who came for their consultation and who take prescribed drugs which have generic alternatives.
METHOD: All patients included received a standard 40 second verbal explanation about generics. Later, the researcher filled out a 18 items test. A descriptive analysis was done taking into account frequencies and applying a bivariable analysis comparing the variable <<accepted change>> with the others.
RESULTS: 71% of the patients accepted the change to generic medicine, 29% did not. Of the latter, 67.4% said that they preferred to consult with the prescribing physician; 45.1% were of the opinion that it would not have the same effect; a 16.1% said that if it was cheaper, it must be of a worse quality; and another 16.1% said that they would only accept the change if it meant saving some money.The researcher perceived distress and discomfort in 23.4% of the patients. He himself felt satisfied in 83.9% of the cases, indifferent in 12.9% and unsatisfied in 3.2%.
CONCLUSION: Providing the adequate information and letting the patients decide for themselves about the substitution of brand for generic drugs resulted in almost three quarters of the cases opting for the change. And this with a minimal professional effort and the added benefit of improving the patient-practioner relationship.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12396938      PMCID: PMC7677959          DOI: 10.1016/s0212-6567(02)79044-6

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  10 in total

1.  [The impact of an intervention strategy in the prescription of generic drugs in a primary care area].

Authors:  M J Calvo Alcántara; A Iñesta García
Journal:  Aten Primaria       Date:  1999-04-30       Impact factor: 1.137

2.  [Generic drug lines: all is not gold that glitters].

Authors:  R Córdoba García
Journal:  Aten Primaria       Date:  1999-10-31       Impact factor: 1.137

3.  [Generic drugs and the rights of substitution].

Authors:  J P Vallée
Journal:  Presse Med       Date:  1999-03-13       Impact factor: 1.228

4.  [Utilization of generic drugs in Spain and Catalonia: possibilities of savings].

Authors:  M Torralba Guirao; A Gilabert Perramon; J Peláez de Loño; M T Faixedas Brunsoms
Journal:  Aten Primaria       Date:  2000-09-15       Impact factor: 1.137

5.  [Generics: authorization to market and quality guarantees].

Authors:  J A De Muylder
Journal:  Rev Med Brux       Date:  2000-09

6.  Buy some today: can generics be safely substituted for brand-name drugs?

Authors:  R P Lesser; G Krauss
Journal:  Neurology       Date:  2001-08-28       Impact factor: 9.910

7.  [Patients' capacity for decision making].

Authors:  P Simón Lorda; J J Rodríguez Salvador; A Martínez Maroto; R M López Pisa; J Júdez Gutiérrez
Journal:  Med Clin (Barc)       Date:  2001-10-13       Impact factor: 1.725

8.  [Generic drugs in Spain: first stage].

Authors:  M Siles Gutiérrez; M Goldaracena Tanco
Journal:  Aten Primaria       Date:  2000 Jul-Aug       Impact factor: 1.137

9.  A physician survey on generic drugs and substitution of critical dose medications.

Authors:  B F Banahan; E M Kolassa
Journal:  Arch Intern Med       Date:  1997-10-13

10.  Family physicians and generic drugs: a study of recognition, information sources, prescribing attitudes, and practices.

Authors:  A D Bower; G L Burkett
Journal:  J Fam Pract       Date:  1987-06       Impact factor: 0.493

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.